Assessment of twelve echovirus virus-neutralisation assays in Europe: recommendations for harmonisation of non-polio enterovirus sero-surveillance studies

References

1. Brouwer L, Moreni G, Wolthers KC, Pajkrt D. World-wide prevalence and genotype distribution of Enteroviruses. Viruses 2021; 13:434 [View Article] [PubMed]
   [Google Scholar]
2. Bubba L, Broberg EK, Jasir A, Simmonds P, Harvala H et al. Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. Lancet Infect Dis 2020; 20:350–361 [View Article] [PubMed]
   [Google Scholar]
3. de Crom SCM, Rossen JWA, van Furth AM, Obihara CC. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr 2016; 175:1023–1029 [View Article] [PubMed]
   [Google Scholar]
4. Rantakallio P, Leskinen M, von Wendt L. Incidence and prognosis of central nervous system infections in a birth cohort of 12,000 children. Scand J Infect Dis 1986; 18:287–294 [View Article] [PubMed]
   [Google Scholar]
5. Meijer A, van der Sanden S, Snijders BEP, Jaramillo-Gutierrez G, Bont L et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 2012; 423:49–57 [View Article] [PubMed]
   [Google Scholar]
6. González-Sanz R, Casas-Alba D, Launes C, Muñoz-Almagro C, Ruiz-García MM et al. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016. Euro Surveill 2019; 24:1800089 [View Article] [PubMed]
   [Google Scholar]
7. Aliabadi N, Messacar K, Pastula DM, Robinson CC, Leshem E et al. Enterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014. Emerg Infect Dis 2016; 22:1387–1394 [View Article]
   [Google Scholar]
8. Casas-Alba D, de Sevilla MF, Valero-Rello A, Fortuny C, García-García J-J et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children’s reference centre in Catalonia. Clin Microbiol Infect 2017; 23:874–881 [View Article] [PubMed]
   [Google Scholar]
9. Grapin M, Mirand A, Pinquier D, Basset A, Bendavid M et al. Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023. Euro Surveill 2023; 28:22 [View Article]
   [Google Scholar]
10. Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis 2022; 22:e35–e40 [View Article] [PubMed]
    [Google Scholar]
11. Harvala H, Benschop KSM, Berginc N, Midgley S, Wolthers K et al. European non-polio enterovirus network: introduction of hospital-based surveillance network to understand the true disease burden of non-polio enterovirus and parechovirus infections in Europe. Microorganisms 2021; 9:1827 [View Article] [PubMed]
    [Google Scholar]
12. Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science 2018; 361:800–803 [View Article] [PubMed]
    [Google Scholar]
13. Karelehto E, Koen G, Benschop K, van der Klis F, Pajkrt D et al. Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016. Euro Surveill 2019; 24:35 [View Article] [PubMed]
    [Google Scholar]
14. Westerhuis B, Kolehmainen P, Benschop K, Nurminen N, Koen G et al. Human parechovirus seroprevalence in Finland and the Netherlands. J Clin Virol 2013; 58:211–215 [View Article] [PubMed]
    [Google Scholar]
15. Couderé K, van der Straten K, Brouwer L, Koen G, van Eijk H et al. Neutralising antibodies against enterovirus and parechovirus in IVIG reflect general circulation: a tool for sero-surveillance. Viruses 2021; 13:1028 [View Article] [PubMed]
    [Google Scholar]
16. Kamau E, Harvala H, Blomqvist S, Nguyen D, Horby P et al. Increase in enterovirus D68 infections in young children, United Kingdom, 2006-2016. Emerg Infect Dis 2019; 25:1200–1203 [View Article] [PubMed]
    [Google Scholar]
17. Zhu R, Cheng T, Yin Z, Liu D, Xu L et al. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg Microbes Infect 2018; 7:2 [View Article] [PubMed]
    [Google Scholar]
18. Kamau E, Bessaud M, Majumdar M, Martin J, Simmonds P et al. Estimating prevalence of Enterovirus D111 in human and non-human primate populations using cross-sectional serology. J Gen Virol 2023; 104:11 [View Article] [PubMed]
    [Google Scholar]
19. Rosenfeld AB, Shen EQL, Melendez M, Mishra N, Lipkin WI et al. Cross-reactive antibody responses against nonpoliovirus Enteroviruses. mBio 2022; 13:e0366021 [View Article] [PubMed]
    [Google Scholar]
20. R Core Team Vienna, Austria; R Foundation for Statistical Computing; 2020 https://www.R-project.org/
21. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493–497 [View Article]
    [Google Scholar]
22. Nguyen D, Simmonds P, Steenhuis M, Wouters E, Desmecht D et al. SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data. Euro Surveill 2021; 26:27 [View Article] [PubMed]
    [Google Scholar]
23. Khoury DS, Wheatley AK, Ramuta MD, Reynaldi A, Cromer D et al. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol 2020; 20:727–738 [View Article] [PubMed]
    [Google Scholar]
24. Manenti A, Molesti E, Maggetti M, Torelli A, Lapini G et al. The theory and practice of the viral dose in neutralization assay: insights on SARS-CoV-2 “doublethink” effect. J Virol Methods 2021; 297:114261 [View Article] [PubMed]
    [Google Scholar]
25. Cooper G. Report of the WHO collaborative study to establish the 1st WHO International Standard for anti-EV71 serum (Human). WHO/BS/2015.2267; 2018
26. Crawt L. Report on the WHO collaborative study to establish the 1st International Standard for Sabin inactivated polio vaccine (sIPV). WHO/BS/2018.2338; 2018